AIIMS) will soon begin Phase 2/3 trials of Hyderabad-based COVID-19 vaccine manufacturer Bharat Biotech’s nasal vaccine.
from Jagran Josh https://ift.tt/38UUjgS
via IFTTT
AIIMS) will soon begin Phase 2/3 trials of Hyderabad-based COVID-19 vaccine manufacturer Bharat Biotech’s nasal vaccine.
0 Comments